…
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Cellebrite DI provides digital intelligence and forensic tools that help law enforcement, government agencies and enterprises extract, decode and analyze data from mobile devices, cloud services and other digital sources. Long-term growth may be supported by rising volumes of digital evidence, increasing cloud and enterprise security needs and the company’s transition toward recurring SaaS and analytics offerings, which could support more predictable revenue. Investors may view the business as an established provider with a global footprint in a specialized market.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 90.68M | -275.98M | -75.56M | 120.76M | 82.31M |
| Net income | 78.33M | -283.01M | -81.10M | 120.81M | 71.40M |
| Selling general administrative | 65.33M | 50.90M | 43.44M | 40.85M | 47.94M |
| Selling and marketing expenses | 154.81M | 132.39M | 110.81M | 97.39M | 76.39M |
| Gross profit | 400.50M | 338.61M | 271.88M | 219.91M | 203.69M |
| Reconciled depreciation | 11.87M | 10.61M | 9.92M | 9.19M | 7.09M |
| Ebit | 66.48M | 56.91M | -74.81M | 1.04M | 13.82M |
| Ebitda | 78.35M | 67.51M | -64.80M | 10.24M | 20.91M |
| Depreciation and amortization | 11.87M | 10.61M | 10.01M | 9.19M | 7.09M |
| Operating income | 66.48M | 56.91M | 33.24M | 1.04M | 13.82M |
| Other operating expenses | 409.19M | 344.30M | 291.87M | 269.61M | 232.42M |
| Interest expense | 0.52M | 349.76M | 0.14M | 119.72M | 68.48M |
| Tax provision | 12.35M | 7.02M | 5.26M | -0.04M | 10.91M |
| Interest income | 23.94M | 18.22M | 8.89M | 1.60M | 68.48M |
| Net interest income | 23.46M | -331.54M | -82.87M | 119.72M | 68.48M |
| Income tax expense | 12.35M | 7.02M | 5.54M | -0.04M | 10.91M |
| Total revenue | 475.68M | 401.20M | 325.11M | 270.65M | 246.25M |
| Total operating expenses | 334.02M | 281.70M | 238.64M | 218.86M | 189.87M |
| Cost of revenue | 75.17M | 62.59M | 53.23M | 50.75M | 42.56M |
| Total other income expense net | 24.20M | -332.89M | -108.80M | 119.72M | 68.48M |
| Net income from continuing ops | 78.33M | -283.01M | -59.38M | 120.81M | 71.40M |
| Net income applicable to common shares | - | - | - | 120.81M | 70.43M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 938.85M | 690.57M | 540.40M | 403.29M | 339.78M |
| Intangible assets | 81.47M | 11.31M | 10.59M | 11.25M | 11.23M |
| Other current assets | 26.23M | 29.07M | 25.80M | 17.09M | 12.82M |
| Total liab | 454.53M | 354.55M | 506.19M | 329.43M | 413.13M |
| Total stockholder equity | 484.32M | 336.02M | 34.21M | 73.86M | -73.35M |
| Other current liab | 348.83M | 61.91M | 43.98M | 45.45M | 54.04M |
| Capital stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Retained earnings | -86.54M | -164.86M | 118.14M | 199.24M | 78.44M |
| Other liab | - | - | - | 111.30M | 226.56M |
| Good will | 119.56M | 28.71M | 26.83M | 26.83M | 26.83M |
| Other assets | - | - | - | 14.24M | 11.76M |
| Cash | 124.46M | 191.66M | 189.52M | 87.64M | 145.97M |
| Total current liabilities | 369.66M | 295.50M | 253.82M | 207.78M | 186.57M |
| Current deferred revenue | - | 217.64M | 196.59M | 152.71M | 122.98M |
| Net debt | -101.79M | -180.69M | -175.39M | -72.29M | -145.97M |
| Short term debt | 4.00M | 4.12M | 4.97M | 5.00M | - |
| Short long term debt total | 22.67M | 10.97M | 14.13M | 15.36M | - |
| Other stockholder equity | 568.64M | 498.80M | -84.98M | -125.71M | -153.16M |
| Property plant equipment | - | - | - | 32.91M | 16.76M |
| Total current assets | 575.85M | 567.59M | 416.53M | 295.93M | 273.21M |
| Long term investments | 97.96M | 36.60M | 28.86M | 22.12M | - |
| Net tangible assets | - | - | - | 35.78M | -111.40M |
| Short term investments | 312.59M | 255.56M | 113.41M | 95.98M | 35.59M |
| Net receivables | 104.97M | 82.36M | 77.27M | 78.76M | 67.50M |
| Inventory | 7.60M | 8.94M | 10.54M | 10.18M | 6.51M |
| Accounts payable | 16.83M | 11.08M | 8.28M | 4.61M | 9.55M |
| Accumulated other comprehensive income | 2.22M | 2.09M | 1.05M | 0.33M | 1.37M |
| Non currrent assets other | 25.50M | 7.68M | 12.89M | 1.73M | 1.96M |
| Non current assets total | 363.00M | 122.97M | 123.86M | 107.36M | 66.57M |
| Capital lease obligations | 22.67M | 10.97M | 14.13M | 15.36M | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | -107.57M | -149.47M | -63.14M | -91.23M | 73.34M |
| Change to liabilities | - | - | - | 33.49M | 26.04M |
| Total cashflows from investing activities | -268.25M | -149.47M | -22.54M | -91.23M | 45.23M |
| Total cash from financing activities | 29.64M | 20.65M | 21.77M | 13.97M | -68.40M |
| Change to operating activities | - | - | - | -19.75M | -1.61M |
| Net income | 78.33M | -283.01M | -81.10M | 120.81M | 71.40M |
| Change in cash | -67.20M | 2.14M | 101.87M | -58.33M | 12.13M |
| Begin period cash flow | 191.66M | 189.52M | 87.64M | 145.97M | 133.85M |
| End period cash flow | 124.46M | 191.66M | 189.52M | 87.64M | 145.97M |
| Total cash from operating activities | 168.96M | 132.17M | 102.06M | 20.58M | 36.05M |
| Issuance of capital stock | - | - | - | - | 0.00M |
| Depreciation | 11.87M | 10.61M | 10.01M | 9.19M | 7.09M |
| Other cashflows from investing activities | 0.86M | -2.04M | -2.69M | - | - |
| Dividends paid | - | - | 0.00M | 0.00M | 100.00M |
| Change to inventory | 1.63M | 0.98M | 0.24M | -3.68M | -1.80M |
| Change to account receivables | -15.78M | -5.83M | 2.27M | -12.88M | -1.96M |
| Sale purchase of stock | - | -0.01M | - | 0.00M | 0.00M |
| Other cashflows from financing activities | 25.05M | 20.65M | 21.77M | 13.97M | 31.60M |
| Change to netincome | - | - | - | -106.60M | -63.03M |
| Capital expenditures | 13.22M | 10.61M | 7.92M | 9.09M | 8.11M |
| Change in working capital | 42.02M | 42.05M | 38.52M | -2.82M | 20.59M |
| Stock based compensation | 44.89M | 30.57M | 19.00M | 13.71M | 6.48M |
| Other non cash items | 36.67M | 335.96M | 110.50M | -117.92M | -67.86M |
| Free cash flow | 155.73M | 121.56M | 94.14M | 11.49M | 27.94M |
Sector: Technology Industry: Software - Infrastructure
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CLBT Cellebrite DI |
- -% |
12.70 | 51.14 | 35.71 | 5.50 | 5.46 | 4.89 | 24.40 |
| MSFT Microsoft Corporation |
-12.04 2.26% |
521.12 | 37.32 | 29.94 | 13.03 | 12.45 | 13.06 | 24.59 |
| ORCL Oracle Corporation |
10.40 8.82% |
128.38 | 21.96 | 17.89 | 5.91 | 7.08 | 7.82 | 14.89 |
| CRWD Crowdstrike Holdings Inc |
3.30 1.46% |
229.06 | 4849.80 | 188.68 | 46.01 | 47.24 | 43.89 | 559.34 |
| FTNT Fortinet Inc |
4.55 3.68% |
128.12 | 60.27 | 43.86 | 16.80 | 80.50 | 16.11 | 43.33 |
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.
94 Shlomo Shmelzer Road, Petah Tikva, Israel, 4970602
972 73 394 8000
1285
| Name | Title | Year Born |
|---|---|---|
| Mr. Yossi Carmil | Founder, CEO & Director | 1967 |
| Ms. Dana Gerner | Chief Financial Officer | 1967 |
| Mr. Arnon Zilberman | Exec. VP of Information Systems & Operations | NA |
| Mr. Ronnen Armon | Chief Products & Technologies Officer | 1963 |
| Anat Earon-Heilborn | VP of Investor Relations | NA |
| Ms. Ayala Berler Shapira | Gen. Counsel | NA |
| Adam Jaffe | VP of Global Communications | NA |
| Ms. Osnat Tirosh | Chief People & Corp. Devel. Officer | 1969 |
| Ms. Lisa Cole | Chief Marketing Officer | NA |
| Mr. Leeor Ben-Peretz | Chief Strategy Officer | 1976 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.